Skip to main content

Table 1 Demographic and general laboratory blood parameters

From: Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial

Parameter

Control

Dapagliflozin 10 mg

P-value

Before

After

Con vs Bef

Bef vs Aft

Age (years)

41.71 ± 6.96

54.00 ± 9.61

0.011

Men, n (%)

4 (57.14)

5 (62.5)

0.833

Weight (kg)

71.57 ± 16.15

83 ± 9.46

66.76 ± 9.79

0.674

0.360

BMI (kg/m2)

25.16 ± 3.56

27.10 ± 2.49

0.549

Waist circumference (cm)

87.86 ± 12.14

100.00 ± 7.33

0.624

AUCGlu (mmol/L·h)

20.02 ± 4.15

46.73 ± 7.49

42.66 ± 7.45

 < 0.001

0.066

HbA1c (%)

5.43 ± 0.23

7.54 ± 1.42

0.002

FBG (mmol/L)

5.03 ± 0.55

7.43 ± 1.58

7.43 ± 0.97

0.005

1.000

FINS (μIU/mL)

9.75 ± 5.05

11.10 ± 4.26

11.49 ± 4.10

0.387

0.468

SUA (μmol/L)

283.57 ± 99.93

347.75 ± 32.53

273.25 ± 43.18

0.175

0.001

TC (mmol/L)

4.98 ± 0.57

5.35 ± 0.83

5.34 ± 0.90

0.376

0.947

TG (mmol/L)

1.69 ± 0.87

2.10 ± 0.98

1.71 ± 0.74

0.441

0.135

HDL-c (mmol/L)

1.36 ± 0.44

1.05 ± 0.13

1.09 ± 0.16

0.144

0.191

LDL-c (mmol/L)

3.04 ± 0.51

3.57 ± 0.79

3.72 ± 1.01

0.186

0.282

  1. Con, control; Bef, before; Aft, after; BMI, body mass index; AUC, area under the curve; Glu, glucose; HbA1c, glycated hemoglobin; FBG, fasting blood glucose; FINS, fasting serum insulin; SUA, serum uric acid; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol